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Abstract A common strategy for conditional
knockout alleles is to ‘‘flox’’ (flank with loxP sites)
a 50 exon within the target gene. Typically, the floxed
exon does not contain a unit number of codons so that
the Cre-mediated recombination event yields a
frameshift and a null allele. Documenting recombi-
nation within the genomic DNA is often regarded as
sufficient proof of a frameshift, and the analysis of
transcripts is neglected. We evaluated a previously
reported conditional knockout allele for the b-subunit
of protein farnesyltransferase. The recombination
event in that allele—the excision of exon 3—was
predicted to yield a frameshift. However, following
the excision of exon 3, exon 4 was skipped by the
mRNA splicing machinery, and the predominant
transcript from the mutant allele lacked exon 3 and
exon 4 sequences. The ‘‘Dexon 3–4 transcript’’ does
not contain a frameshift but rather is predicted to
encode a protein with a short in-frame deletion. This
represents a significant concern when studying an
enzyme, since an enzyme with partial function could
lead to erroneous conclusions. With thousands of new
conditional knockout alleles under construction within
mouse mutagenesis consortiums, the protein farne-
syltransferase allele holds an important lesson—to
characterize knockout alleles at both the DNA and
RNA levels.
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Introduction
In preparing a conditional knockout allele, loxP sites
are typically inserted into different introns of a target
gene (‘‘floxing’’ an exon or exons) (Ku¨hn et al. 1995;
Rajewsky et al. 1996; Schwenk et al. 1995). With the
expression of Cre recombinase, the exon(s) of the
gene is removed, resulting in a knockout allele.
Typically, care is taken to ‘‘flox’’ an exon without a
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unit number of codons (i.e., an exon where the
number of nucleotides in the exon is not evenly
divisible by three) so that the recombination event
yields a frameshift. A frameshift is important for
creating a null allele (Hasty et al. 2000). Other
considerations relevant to producing a null allele
have been reviewed by Hasty et al. (2000).
A conditional knockout allele for Fntb, the gene
encoding the b-subunit of protein farnesyltransferase
(FTase), was reported by Mijimolle et al. (2005).
FTase catalyzes the farnesylation (covalent attach-
ment of a 15-carbon isoprenyl lipid) of proteins
carrying a carboxyl-terminal CaaX motif (Casey and
Seabra 1996). In Mijimolle’s Fntb conditional
knockout allele (Mijimolle et al. 2005), exon 3
(73 bp in length) was flanked by loxP sites. As
expected, the expression of Cre recombinase excised
exon 3, and that recombination event was well
characterized at the genomic DNA level (Mijimolle
et al. 2005). The excision of exon 3 was predicted by
Mijimolle et al. (2005) to yield a frameshift and a null
allele, but transcripts from the allele were not
analyzed.
Without question, the Cre-mediated excision of
exon 3 reduced FTase activity. Germline homozy-
gosity for the recombined allele prevented normal
embryonic development, and fibroblasts homozygous
for the mutant allele had reduced FTase activity
(Mijimolle et al. 2005). On the other hand, several
features of Mijimolle’s study (Mijimolle et al. 2005)
were unexpected. For example, in homozygous
knockout fibroblasts, H-RAS remained associated
with membrane fractions (Mijimolle et al. 2005).
That was peculiar because the association of H-RAS
with membranes is utterly dependent on protein
farnesylation (Berzat et al. 2005, 2006; Chenette
et al. 2005; Takahashi et al. 2005). The prenylation of
another farnesylated protein, HDJ-2, was only par-
tially blocked in their homozygous Fntb-deficient
fibroblasts (Mijimolle et al. 2005). Also, the Fntb
knockout had no effect on tumorigenesis, while FTase
inhibitor drugs retard tumor growth (Barrington et al.
1998; Omer et al. 2000).
In this study, we examined the Fntb allele
generated by Mijimolle et al. (2005). We found that
the predominant transcript produced by the mutant
allele did not contain a frameshift but rather encoded
a protein with a short in-frame deletion.
Materials and methods
Genetically modified mice
Mice harboring an Fntb conditional knockout allele
(Fntblox) and a fully recombined knockout allele
(FntbD) (Mijimolle et al. 2005) were obtained from
the Fundacio´n Centro Nacional De Investigaciones
Oncolo´gicas Carlos III. Mice were genotyped by PCR
with oligonucleotide primers 50-CTGGAGGCTGG
GAAGCTGGA-30 and 50-GCCTAAGAGCCGTGT
GGGGGT-30. The wild-type allele yielded a 1,940-
bp fragment; the Fntblox allele, a 907-bp fragment;
the FntbD allele, a 557-bp fragment.
Fibroblasts from Fntblox/D embryos were obtained
as previously described (Todaro and Green 1963).
Mouse embryonic fibroblasts (MEFs) (80% confluent)
grown on 6-well plates were infected with Cre
adenovirus (20 ll/well, 3 9 1010 pfu/ml, Gene Trans-
fer Vector Core, University of Iowa), and cells extracts
were prepared 5 days later. In some experiments, cells
were treated with Cre adenovirus only once. A single
treatment with Cre adenovirus generally did not lead to
100% complete recombination; however, those exper-
iments were nevertheless useful because they allowed
us to analyze Cre-recombination events.
In other experiments, Cre adenovirus treatment
was repeated three times, so as to yield complete
recombination. Before harvesting the latter cells,
genotyping was performed to make sure that the
Fntblox/D cells had been converted to the FntbD/D
genotype. In some experiments, fibroblasts were
treated with a protein farnesyltransferase inhibitor
(FTI) (ABT-100, 5 lM) (Ferguson et al. 2005).
RT-PCR reactions
RT-PCR products were obtained from Fntblox and FntbD
alleles with exon1/exon5, exon1/exon8, and exon1/
exon4 primer sets. Exon 1 forward primer: 50-TACAG
CGCTCGCAGCTCTCC-30; exon 5 reverse primer: 50-
CATTGACGGCTGCATAAGTG-30; exon 8 reverse
primer: 50-GCCAAGCCACAGAAGGTGTA-30); exon
4 reverse primer: 50-CTGCTACTGGATCCTGCAC
A-30. Total RNA was extracted from MEFs or tissues
with the RNeasy Mini kit (Qiagen); reverse transcriptase
reactions were carried out with 500 ng of RNA that
had been treated with DNase (DNA-Free, Ambion),
484 Transgenic Res (2009) 18:483–489
123
Superscript III (Invitrogen), and a mixture of oligo-dT
(Invitrogen) and random primers (Invitrogen). The
thermal cycling conditions were as follows: 95C for
3 min, 95C for 15 s, 60C for 30 s, and 72C for 15 s,
for a total of 26 cycles.
Western blots
Cell extracts were electrophoresed on 4–12% gradi-
ent polyacrylamide Bis–Tris gels (Invitrogen), and
the proteins were electrophoretically transferred to a
nitrocellulose membrane for western blotting. The
antibody dilutions were 1:400 for anti-lamin A/C goat
IgG (sc-6215, Santa Cruz Biotechnology), 1:500 for
anti-HDJ-2 mouse IgG (NeoMarkers), and 1:1000 for
anti-actin goat IgG (sc-1616, Santa Cruz Biotech-
nology). After washing the membrane, the blots were
incubated with secondary antibodies (1:5000 IRDye
700 anti-goat IgG antibody and 1:5000 IRDye 800
anti-mouse IgG antibody). Signals were detected with
the Odyssey infrared imaging system (LI-COR
Biosciences).
Results and discussion
We generated Fntblox/D MEFs and incubated them
with Cre adenovirus (Anton and Graham 1995) or an
adenovirus encoding b-galactosidase. As expected,
the floxed segment of DNA (spanning exon 3) was
removed by Cre recombinase (Fig. 1a, b). The
location of the loxP sites in the Fntblox allele was
documented by DNA sequencing. As noted earlier,
the excision of exon 3 was predicted to yield a
frameshift (Mijimolle et al. 2005). To characterize
the transcripts from the mutant allele, we performed
RT-PCR reactions spanning sequences encoded by
exons 1–5 and exons 1–8 (Fig. 2a–c). Following the
excision of exon 3 from the genomic DNA, exon 4
was skipped by the mRNA splicing machinery. Thus,
the predominant transcript from the FntbD allele in
Fntblox/D MEFs lacked exon 3 and exon 4 sequences
(Fig. 2b, c). After a single round of Cre adenovirus
infection, the amount of ‘‘Dexon 3–4 transcript’’ was
substantial, but some non-recombined (wild-type)
transcripts remained (Fig. 2b). To achieve complete
recombination, we treated Fntblox/D MEFs with three
rounds of Cre adenovirus (Fig. 2c). In the latter cells,
none of the wild-type Fntb transcript remained.
The identity of the RT-PCR product corresponding
to the ‘‘Dexon 3–4 transcript’’ was confirmed by
DNA sequencing (Fig. 2d). The Dexon 3–4 transcript
was the predominant transcript from the FntbD allele
within the tissues of Fntblox/D mice (Fig. 2e). The
Dexon 3–4 transcript is predicted to encode a protein
with an in-frame deletion of amino acids 70–124.
As judged by ethidium bromide–stained agarose
gels of RT-PCR reactions, the levels of the Dexon 3–4
transcript in Fntblox/D MEFs and mouse tissues were
comparable to those of the wild-type Fntb transcript
(Fig. 2b, c, e). Finding high levels of the Dexon 3–4
transcript was not surprising because the Dexon 3–4
transcript lacks a premature stop codon and would not
be subject to nonsense-mediated mRNA decay.
Trace amounts of a Dexon 3 RT-PCR product
could be detected between the wild-type and Dexon
3–4 RT-PCR products (Fig. 2b, e). The identity of the
Dexon 3 RT-PCR product was confirmed by DNA
Fig. 1 A conditional knockout allele for Fntb, the gene
encoding the b-subunit of FTase. a Strategy of Mijimolle
et al. 2005 to create a conditional Fntb knockout allele. Cre-
mediated excision of the floxed DNA segment removes exon 3,
a deletion that was predicted to yield a frameshift. b PCR
strategy to genotype mice or mouse embryonic fibroblasts.
The PCR product yielded a 1,940-bp fragment from the
wild-type Fntb allele, a 907-bp fragment from the Fntblox
allele, and a 557-bp fragment from the FntbD allele. The two
extra bands, with apparent lengths of*1,100 and 1,800 bp, are
heteroduplexes
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Fig. 2 Characterizing transcripts from the FntbD allele. a
Schematic illustrating RT-PCR products obtained from Fntblox
and FntbD alleles with an exon1/exon5 primer set and an exon1/
exon8 primer set. b Ethidium bromide-stained 1.5% agarose gel
showing the RT-PCR products generated from RNA prepared
from wild-type (WT) MEFs, b-galactosidase adenovirus-treated
Fntblox/D MEFs, and Cre adenovirus-treated Fntblox/D MEFs.
With the exon1/exon5 primer set, the fainter amplicon between
the 504-bp wild-type Fntb RT-PCR product and the 339-bp
Dexon 3–4 RT-PCR product is the 412-bp Dexon 3 RT-PCR
product. The numbers on the left indicate sizes of the RT-PCR
products. c Ethidium bromide-stained 1.5% agarose gel showing
the RT-PCR products (with the exon1/exon8 primer set) with
RNA from wild-type (WT) MEFs and Fntblox/D MEFs that had
been treated three times over 7 days with b-galactosidase
adenovirus and Cre adenovirus. The RT-PCR reaction yields a
796-bp wild-type band and a 631-bp ‘‘Dexon 3–4’’ product. The
numbers on the left indicate sizes of the RT-PCR products. d
DNA sequencing chromatogram showing the sequence of the
Dexon 3–4 RT-PCR product. The DNA fragment that was
sequenced and purified from the agarose gel with the QIAquick
Gel Extraction Kit (Qiagen). e Ethidium bromide-stained
agarose gel showing the RT-PCR products generated from the
exon1/exon5 primer set and RNA from Fntblox/D MEFs, the
tissues of an Fntblox/D mouse, and tissues of an Fntblox/lox mouse.
The predominant products were the 504-bp wild-type Fntb
RT-PCR product and the 339-bp Dexon 3–4 RT-PCR product.
The numbers on the left indicate sizes of the RT-PCR products. f
Schematic illustrating RT-PCR products obtained from Fntblox
and FntbD alleles with an exon1/exon4 primer set. g Ethidium
bromide-stained agarose gel showing the RT-PCR products
generated from the exon1/exon4 primer set and RNA prepared
from WT MEFs, b-galactosidase adenovirus-treated Fntblox/D
MEFs, Cre adenovirus-treated Fntblox/D MEFs, and tissues of an
Fntblox/D mouse. A strong 353-bp WT RT-PCR product and a
fainter 280-bp Dexon 3 RT-PCR product could be detected in
tissues of an Fntblox/D mouse and in Fntblox/D MEFs. After
treating the cells with Cre adenovirus, the Dexon 3 RT-PCR
product was more intense. The numbers on the left indicate sizes
of the RT-PCR products
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sequencing (not shown). The Dexon 3 transcript
could also be detected by RT-PCR with an exon1/
exon4 primer set (this primer set cannot detect the
Dexon 3–4 transcript) (Fig. 2f, g). The level of the
Dexon 3 transcript, relative to the wild-type transcript,
was low (Fig. 2b, e).
Prelamin A and HDJ-2 are both CaaX proteins that
are farnesylated by FTase. In Cre adenovirus–treated
Fntblox/D MEFs (three rounds of infection), we found
that HDJ-2 prenylation was blocked by only 50%
(Fig. 3a). These results were essentially identical to the
findings reported earlier by Mijimolle et al. (2005);
they had produced FntbD/D fibroblasts from a single
cell clone and found that only *50% of HDJ-2
prenylation was blocked. In control experiments with
wild-type fibroblasts, we found that a pharmacologic
inhibitor of FTase blocked almost all HDJ-2 farnesy-
lation (Fig. 3a).
We also found small amounts of prelamin A
accumulation in these cells, indicating a partial block-
ade of lamin A biogenesis (Fig. 3b). Normally,
prelamin A is efficiently converted to mature lamin A
and prelamin A is virtually undetectable in cells. In the
absence of farnesylation, prelamin A cannot be con-
verted to mature lamin A and nonfarnesylated
prelamin A accumulates in cells. Interestingly, the
amount of prelamin A in Cre adenovirus–treated
Fntblox/D MEFs was small but increased when the
cells were treated with an FTI (Fig. 3b). The existence
of nonfarnesylated HDJ-2 and prelamin A in Cre
adenovirus–treated Fntblox/D MEFs provided unequiv-
ocal evidence for markedly reduced FTase activity. On
the other hand, the effects of the Fntb gene inactivation
on HDJ-2 prenylation and lamin A biogenesis were less
than we would have expected with a complete Fntb
knockout. Also, we observed greater inhibition of
HDJ-2 prenylation when Cre adenovirus–treated
Fntblox/D MEFs were treated with an FTase inhibitor
(Toth et al. 2005; Yang et al. 2005).
At this point, we do not know if a mutant b-chain
lacking amino acids 70–124 would be able to associate
with the a-chain and yield an FTase complex with
residual enzymatic activity. However, this possibility
is not farfetched; deletions of[100 amino acids from
the amino terminus of the b-subunit of yeast FTase do
not prevent association with the a-chain (Urano et al.
2000). We also do not know if the internally truncated
b-chain would yield a prenyltransferase with altered
specificities. Addressing these issues with biochemical
studies would be extremely challenging. In fact, we
believe that biochemical experiments to fully exclude
trace amounts of residual FTase activity from
Mijimolle’s FntbD allele (and biochemical experi-
ments to unequivocally prove that the prenylation in
FntbD/D cells is due to geranylgeranyltransferase, type
I) would be virtually impossible and ultimately would
yield murky results.
In some knockout experiments, a 99.5%-complete
knockout might be entirely satisfactory. However,
when the goal is to investigate the physiologic
importance of FTase, a ‘‘leaky’’ knockout allele is
suboptimal. When faced with an in-frame deletion and
the possibility of an enzyme with partial function, one
should strongly consider generating a new conditional
knockout allele.
In constructing their conditional Fntb knockout
allele, Mijimolle et al. (2005) reported that they had
deleted 967 bp of intron 2 and 297 bp of intron 3.
Based on their paper, the intron 2 deletion started
114 bp 50 to the intron 2–exon 3 junction, and the intron
3 deletion started 146 bp 30 to the exon 3–intron 3
junction. These descriptions did not match our DNA
sequencing data; the deletions started 155 bp 50 and
88 bp 30 to exon 3. We believe that introducing
deletions this close to intron–exon junctions is hazard-
ous, and we would not be surprised if the intron
deletions contributed to the aberrant mRNA splicing.
In any case, we suspect that the aberrant splicing event
Fig. 3 Western blot analysis of wild-type (WT), Fntblox/D, and
Fntblox/D MEFs that had been treated with Cre adenovirus or an
FTI (ABT-100, 5 lM). a Western blots for HDJ-2; the slower
migrating protein is nonfarnesylated HDJ-2. b Western blot for
lamins A/C and prelamin A in the presence and absence of a
specific FTI (ABT-100, 5 lM)
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in Mijimolle’s Fntb allele would have been overlooked
by many laboratories. Conditional knockout alleles are
almost always well characterized at the genomic DNA
level, and the excision of an exon is widely regarded as
proof of a null allele. The transcripts from knockout
alleles are often not characterized, even when exper-
imental findings raise the possibility of a leaky allele
(Mijimolle et al. 2005).
The NIH has funded the Knockout Mouse Project
(KOMP) to create a toolbox of mutant mouse alleles
for the biomedical research community (Collins et al.
2007a, b). Thousands of conditional knockout alleles
are now being generated. KOMP investigators intro-
duce a loxP site and a ‘‘splice acceptor–lacZ reporter
cassette’’ into one intron and a second loxP site into
another intron (Collins et al. 2007b). The initial
targeting event yields a knockout allele containing a
b-galactosidase reporter. However, the lacZ cassette
(which is flanked by FRT sites) can be excised with
Flp recombinase, creating a conditional knockout
allele in which an exon(s) is flanked by loxP sites
(i.e., an allele that is structurally similar to the one
created by Mijimolle et al. 2005). The studies reported
here suggest that caution is warranted with conditional
knockout alleles. In experiments with these alleles,
whether they are obtained from KOMP or elsewhere, it
is important to consider the possibility of unexpected
splicing events. This is particularly important for any
project where the creation of a true null allele is
deemed important.
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